1-4 of 4
Hye-Sung Park
Close
Sort by
Journal Articles

A Combination Therapy with Dendritic Cells, Pomalidomide and Programmed Death-Ligand 1 Blockade Exerts a Potent Antitumor Immunity in a Murine Model of Multiple Myeloma

Je-Jung Lee, MD PhD, Tan-Huy Chu, Manh-Cuong Vo, Hye-Sung Park, Thangaraj Jaya Lakshmi, Seo-Yeon Ahn, MD, Ga-Young Song, Sung-Hoon Jung, MD, Hyeoung-Joon Kim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1819.
https://doi.org/10.1182/blood-2019-127964
Published: 2019
Journal Articles

Multimodality Targeting of Dendritic Cell Vaccination Combined with Immunomodulatory Drug and Immune Checkpoint Blockade Has Synergistically Induced a Marked Tumor Regression By Modulating Tumor Microenvironment in a Murine Myeloma Model

Manh-Cuong Vo, Hyun-Ju Lee, Sung-Hoon Jung, MD, Thangaraj Jaya Lakshmi, Hye-Sung Park, Tan-Huy Chu, Hyeoung-Joon Kim, Je-Jung Lee, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5453.
https://doi.org/10.1182/blood.V130.Suppl_1.5453.5453
Published: 2017
Journal Articles

Dendritic Cell Vaccination Combined with Pomalidomide and Dexamethasone Ameliorated Antitumor Immunity By Skewing Immuno-Suppressive Status Toward Immuno-Supportive Status in a Murine Myeloma Model

Sung-Hoon Jung, MD, Seoyun Yang, Hyun-Ju Lee, Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Hye-Sung Park, Tan-Huy Chu, Hyeoung-Joon Kim, Je-Jung Lee, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5454.
https://doi.org/10.1182/blood.V130.Suppl_1.5454.5454
Published: 2017
Journal Articles

Cytoplasmic Transduction Peptide-Fused Recombinant Tumor-Associated Antigens Elicit Potent Myeloma-Specific Cytotoxic T Lymphocytes By Loading Onto Dendritic Cells: Implications of Feasible Tumor Antigens for Clinical Application Against Multiple Myeloma

Hyun-Ju Lee, Sung-Hoon Jung, MD, Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Hye-Sung Park, Tan-Huy Chu, Hyeoung-Joon Kim, Je-Jung Lee, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5455.
https://doi.org/10.1182/blood.V130.Suppl_1.5455.5455
Published: 2017